C67 Malignant neoplasm of bladder

Name of the Condition

• Malignant neoplasm of bladder
• Bladder cancer

Summary

Malignant neoplasm of the bladder refers to cancer that originates in the bladder's tissues. This condition involves abnormal cell growth that can invade surrounding structures and spread to other parts of the body. It is a type of urothelial carcinoma, the most common form of bladder cancer.

Causes

The exact cause of bladder cancer is not fully understood, but it often involves genetic mutations in bladder cells. These mutations may be triggered by exposure to carcinogens, which can damage DNA and lead to uncontrolled cell growth.

Risk Factors

• Smoking: Tobacco use is a major risk factor, as carcinogens from smoke are excreted in urine.
• Occupational exposure: Chemicals like aromatic amines (used in dye, rubber, or leather industries) increase risk.
• Age: Most cases occur in individuals over 55.
• Gender: Males are more frequently affected than females.
• Chronic bladder inflammation: Conditions like recurrent infections or long-term catheter use may contribute.
• Family history: A genetic predisposition can elevate risk.

Symptoms

• Blood in urine (hematuria), which may be visible or detected microscopically.
• Frequent urination or urgent need to urinate.
• Painful urination or discomfort.
• Pelvic pain or lower back pain.
• Urinary tract infections that do not resolve with treatment.

Diagnosis

Diagnosis typically involves a combination of tests to evaluate symptoms and confirm cancer. Urinalysis checks for blood or abnormal cells, while urine cytology examines cells for malignancy. Cystoscopy allows direct visualization of the bladder using a thin, lighted tube. Biopsy samples taken during cystoscopy are analyzed for cancerous cells. Imaging tests like CT or MRI scans assess tumor extent and potential spread.

Treatment Options

Treatment depends on the cancer's stage and grade. Options include transurethral resection of bladder tumor (TURBT) to remove localized growths, intravesical therapy (e.g., chemotherapy or immunotherapy) to target remaining cells, and radical cystectomy for advanced cases. Radiation therapy or systemic chemotherapy may be used for metastatic disease or when surgery is not feasible.

Prognosis and Follow-Up

Prognosis varies based on the cancer's stage at diagnosis. Early-stage tumors have a better outlook, while advanced or recurrent cancers carry higher risks. Regular follow-up with cystoscopy and imaging is essential to monitor for recurrence. Long-term surveillance helps detect new tumors or progression early.

Complications

Complications can include urinary incontinence, especially after bladder removal surgery. Infections, bleeding, or obstruction of the urinary tract may occur. Metastasis to lymph nodes, bones, or other organs is a serious concern in advanced cases.

Lifestyle & Prevention

• Quit smoking to reduce carcinogen exposure.
• Avoid occupational chemicals or use protective equipment if exposure is unavoidable.
• Stay hydrated to dilute urine and reduce bladder irritation.
• Maintain a healthy diet rich in fruits and vegetables.
• Promptly treat chronic bladder conditions to minimize inflammation.

When to Seek Professional Help

Seek medical attention if you experience blood in urine, persistent urinary changes, or unexplained pelvic pain. Early evaluation is critical for timely diagnosis and treatment. Do not ignore symptoms that suggest bladder issues, as they may indicate cancer or other serious conditions.

Tips for Medical Coders

For ICD-10-CM code C67, document the specific site of the bladder neoplasm (e.g., anterior wall, posterior wall) if known, as this may refine coding. Ensure documentation supports the diagnosis, including clinical findings, biopsy results, or imaging. Note any overlapping sites or multifocal tumors, as these may require additional coding specificity. Avoid assumptions about the cancer's behavior (e.g., invasive vs. in situ) without explicit documentation.